Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Qiagen ( (QGEN) ) just unveiled an announcement.
Qiagen N.V., a company involved in the biotechnology sector, has been informed by the Netherlands Authority for the Financial Markets (AFM) about a notification regarding its institution. The notification, disclosed on the AFM website, involves BlackRock, Inc., which holds a significant capital interest and voting rights in Qiagen. This announcement highlights BlackRock’s substantial indirect holdings in Qiagen, which could influence the company’s market position and stakeholder interests.
The most recent analyst rating on (QGEN) stock is a Hold with a $42.50 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.
More about Qiagen
Average Trading Volume: 1,429,877
Technical Sentiment Signal: Buy
Current Market Cap: $10.47B
For a thorough assessment of QGEN stock, go to TipRanks’ Stock Analysis page.